BLT 0.00% 2.6¢ benitec biopharma limited

We have some company for the IPO and we will be at an attractive...

  1. 1,011 Posts.
    lightbulb Created with Sketch. 84
    We have some company for the IPO and we will be at an attractive price.

    NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

    Week of August 3:

    Aimmune Therapeutics Inc. - Brisbane, Calif., 8.3 million shares, priced $14 to $16, managed by BofA Merrill Lynch, Credit Suisse, and Piper Jaffray. Proposed Nasdaq symbol AIMT. Business: Developing an oral immunotherapy designed to lessen the effects of peanut allergies.

    Amplify Snack Brands Inc. - Austin, Texas, 15 million shares, priced $14 to $16, managed by Goldman Sachs, Jefferies, and Credit Suisse. Proposed NYSE symbol BETR. Business: PE-backed seller of SkinnyPop brand popcorn.

    Benitec Biopharma Ltd. - Balmain, Australia, 5 million American depositary shares, each representing 20 ordinary shares, priced at $13, managed by BMO Capital Markets. Proposed Nasdaq symbol BNTC. Business: Developing gene therapies for hepatitis C based on RNA interference. Ordinary shares trade in Australia.

    GC Aesthetics plc - Dublin, Ireland, 5.35 million ordinary shares, priced $13 to $15, managed by BofA Merrill Lynch, Deutsche Bank, and Cowen & Co. Proposed Nasdaq symbol GCAA. Business: Provider of silicone breast implants globally, outside the U.S.

    Philadelphia Energy Solutions Inc. - Philadelphia, 15.15 million class A shares, priced $15 to $18, managed by BofA Merrill Lynch, Credit Suisse, and Goldman Sachs. Proposed NYSE symbol PESC. Business: Carlyle-backed owner of a crude oil refinery and rail terminal in Philadelphia.

    Planet Fitness Inc. - Newington, N.H., 13.5 million class A shares, priced $14 to $16, managed by J.P. Morgan, BofA Merrill Lynch, and Jefferies. Proposed NYSE symbol PLNT. Business: Franchised low-cost gym chain with over 1,000 locations in the U.S.

    Sunrun Inc. - San Francisco, 17.9 million shares, priced $13 to $15, managed by Credit Suisse, Goldman Sachs, and Morgan Stanley. Proposed Nasdaq symbol RUN. Business: Second-largest residential solar company in the U.S.

    Zynerba Pharmaceuticals Inc. - Devon, Pa., 3 million shares, priced,$13 to $15, managed by Jefferies, and Piper Jaffray. Proposed Nasdaq symbol ZYNE. Business: Preclinical biotech developing cannabinoid-based therapies for osteoarthritis and epilepsy.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.